FilingReader Intelligence
Shanghai Pharma subsidiary fined for antitrust violations
March 27, 2025 at 10:15 PM UTC•By FilingReader AI
Shanghai Pharmaceuticals Holding (SSE:601607) announced that its subsidiary, Shanghai Xinyi United Pharmaceutical Materials Co. Ltd., received an administrative penalty from the Shanghai Market Supervision and Administration Bureau for violating antitrust laws. The penalty totals ¥165,806,991.69, comprising ¥115,471,142.40 in confiscated illegal gains and a ¥50,335,849.29 fine, equivalent to 2% of 2023 sales of the drug in question.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
SSE:601607•Shanghai Stock Exchange
News Alerts
Get instant email alerts when Shanghai Pharmaceuticals Holding publishes news
Free account required • Unsubscribe anytime